Home > Event > On-Demand Webinars > Optimizing Drug-Dose Checking to Minimize Alert Fatigue

Optimizing Drug-Dose Checking to Minimize Alert Fatigue

Drug dosing errors account for nearly 40% of all preventable medical errors and could prove harmful to patients and costly to healthcare organizations. Join MetroHealth System CMIO Dr. David Kaelber for a look at how his institution’s strategic approach to customizing its EHR-integrated drug dosing data lead to both improved patient outcomes and a reduction in irrelevant alerts and alert fatigue, as well as techniques for optimizing your drug decision support system.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

From mg to kg: first steps towards a scalable process for drug substances

on24

In this webinar, Anders Högdin, Senior Sales Director at Recipharm discusses the common challenges companies encounter during upscaling. He also outlines the key considerations during the medicinal and process chemistry planning phases, the regulatory requirements and the steps companies can take to streamline the process.
Watch Now

The Tablet Characterization with Regulatory Compliance Methods

At Natoli Scientific, we’re in the lab every day compiling thorough USP Tablet Compression Characterization data to help you identify and solve compaction problems and provide solutions.
Watch Now

The Safety Evaluation and Surveillance of Generic Drugs

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars.
Watch Now

Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models

Since the first immune checkpoint blocker ipilimumab was approved by the US FDA in 2011, more drug companies have sought to develop their own immune therapy drugs.
Watch Now

From mg to kg: first steps towards a scalable process for drug substances

on24

In this webinar, Anders Högdin, Senior Sales Director at Recipharm discusses the common challenges companies encounter during upscaling. He also outlines the key considerations during the medicinal and process chemistry planning phases, the regulatory requirements and the steps companies can take to streamline the process.
Watch Now

The Tablet Characterization with Regulatory Compliance Methods

At Natoli Scientific, we’re in the lab every day compiling thorough USP Tablet Compression Characterization data to help you identify and solve compaction problems and provide solutions.
Watch Now

The Safety Evaluation and Surveillance of Generic Drugs

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars.
Watch Now

Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models

Since the first immune checkpoint blocker ipilimumab was approved by the US FDA in 2011, more drug companies have sought to develop their own immune therapy drugs.
Watch Now
More On-Demand Webinars

Spotlight

resources

resource image

How long will the world wait for the next pandemic of antimicrobial resistance before we act?

Article

resource image

Driving Down Drug Costs: How Real-Time Transparency in PBMs Can Make a Difference

Article